Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Tafenoquine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,268Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    60 Degrees Pharmaceuticals Announces Expansion of Arakoda Sales
    60 Degrees Pharmaceuticals Announces Expansion of Arakoda Sales

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203873/0/en/60-Degrees-Pharmaceuticals-Announces-Expansion-of-ARAKODA-Sales-and-Marketing-in-2026.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    60 Degrees Pharmaceuticals Announces Clinical Site Now Open
    60 Degrees Pharmaceuticals Announces Clinical Site Now Open

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192770/0/en/60-Degrees-Pharmaceuticals-Announces-Clinical-Site-Now-Open-for-Patient-Enrollment-for-the-B-FREE-Chronic-Babesiosis-Study-at-Mount-Sinai-Icahn-School-of-Medicine.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    60 Degrees Drug Clears Babesia in Relapsing Babesiosis Study
    60 Degrees Drug Clears Babesia in Relapsing Babesiosis Study

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3166954/0/en/60-Degrees-Pharmaceuticals-Announces-No-Detection-of-Babesia-Infection-in-First-Patient-Following-Treatment-with-Tafenoquine-in-Relapsing-Babesiosis-Study.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share
    60 Degrees, Tulane to Study Tafenoquine for Lyme, Others
    60 Degrees, Tulane to Study Tafenoquine for Lyme, Others

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3117175/0/en/60-Degrees-Pharmaceuticals-and-Tulane-University-Sign-Research-Agreement-to-Study-Tafenoquine-Against-Lyme-and-Bartonella-Bacteria.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    60 Degrees Pharma Forecasts $1.1 B Babesiosis Market for Arakoda
    60 Degrees Pharma Forecasts $1.1 B Babesiosis Market for Arakoda

    15 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/15/3115462/0/en/60-Degrees-Pharmaceuticals-Defines-Potential-Human-Babesiosis-Market-Size-for-ARAKODA-tafenoquine-Annual-Max-TAM-Sales-of-245-Million-Cumulative-through-Patent-Expiration-1-1-Billi.html

    GLOBENEWSWIRE
    15 Jul 2025
    Share Share
    60 Degrees Seeks FDA MUMS Status for Tafenoquine by 2025
    60 Degrees Seeks FDA MUMS Status for Tafenoquine by 2025

    14 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/14/3115142/0/en/60-Degrees-Pharmaceuticals-to-Submit-MUMS-Minor-Use-Minor-Species-Designation-Request-to-FDA-for-Tafenoquine-for-Acute-Canine-Babesiosis-in-2025.html

    GLOBENEWSWIRE
    14 Jul 2025
    Share Share